Supplementary Table 6-7 from Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer by Chang Xu (102022)

Supplementary Table 1-3 from Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer by Chang Xu (102022)

Image1_The new oncogene transmembrane protein 60 is a potential therapeutic target in glioma.TIF by Fengdong Yang (10875921)

“…Thus, the new oncogene transmembrane protein 60 might be an effective therapeutic target for the clinical treatment of glioma.…”

Antifungal effect of WSWE on <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

Phytochemical compositional analysis of WSWE. by Acharya Balkrishna (5640038)

Subjects:

Effect of withanone and withaferin A purified from WSWE on <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Subjects:

Determination of minimum fungicidal concentration of WSWE against <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

Micromorphological impact of WSWE treatment on <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Subjects:

Proposed model of mode of action of WSWE as anti-fungal agent. by Acharya Balkrishna (5640038)

Subjects:

WSWE treatment reduced total ergosterol amount in <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Subjects:

Excel spreadsheet containing, in separate sheets (for each figure), the underlying numerical datas for Figure panels 1A, 1B, 1C, 2B, 3A, 3B, 3C, 4C, 4D, 4E, 4F, 4G, 5B, 8C and 8D. by Acharya Balkrishna (5640038)

Subjects:

Time kill kinetics of WSWE against <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

Therapeutic effect of TAS5315 on the decrease in bone strength in a mouse CIA model. by Daichi Akasaka (14670684)

Primer sequences with the respective targeted ESBL clusters. by Dita Gudra (4439767)

Subjects:

An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced <i>in vitro</i> macrophage retention for an anti-hepatitis B therapeutic prospect by Mohamed Hamdi (8282427)

PD-1 and CXCR4 expression in PDAC tumors and PDOs. by Megan M. Harper (13014734)

Subjects:

<i>PD-1</i> knockdown in MIAPaCa-2 cells attenuates CXCR4 downstream pathways. by Megan M. Harper (13014734)

Subjects:

PD-1 and CXCR4 expression in PDAC cells and PDOs. by Megan M. Harper (13014734)

Subjects:

CXCR4 inhibition leads to PD-1 translocation to the cell membrane. by Megan M. Harper (13014734)

Subjects:

Co-immunoprecipitation studies in MIAPaCa-2 and PANC-1 cell lines. by Megan M. Harper (13014734)

Subjects: